These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2326862)

  • 1. The course of untreated acute rejection and effect of repeated anti-CD3 monoclonal antibody treatment in rhesus monkey liver transplantation.
    Steinhoff G; Jonker M; Gubernatis G; Wonigeit K; Lauchart W; Bornscheuer A; Pichlmayr R
    Transplantation; 1990 Apr; 49(4):669-74. PubMed ID: 2326862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of skin allograft survival of a monoclonal antibody specific for a polymorphic CD3-like cell surface molecule in rhesus monkeys.
    Nooij FJ; Jonker M
    Eur J Immunol; 1987 Aug; 17(8):1089-93. PubMed ID: 3113976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotoxin FN18-CRM9 induces stronger T cell signaling than unconjugated monoclonal antibody FN18.
    Hamawy MM; Tsuchida M; Cho CS; Manthei ER; Fechner JH; Knechtle SJ
    Transplantation; 2001 Aug; 72(3):496-503. PubMed ID: 11502982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of CD3epsilon in cynomolgus and rhesus monkeys and their relevance to anti-CD3 antibodies and immunotoxins.
    Liu YY; Wang Z; Thomas J; Goodwin KJ; Stavrou S; Neville DM
    Immunol Cell Biol; 2007 Jul; 85(5):357-62. PubMed ID: 17325695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term kidney graft survival by delayed T cell ablative treatment in rhesus monkeys.
    Jonker M; Ringers J; Ossevoort MA; Slingerland W; van den Hout Y; Haanstra K; Wubben J; Kuhn E; Friend P; Calne R
    Transplantation; 2002 Mar; 73(6):874-80. PubMed ID: 11923686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.
    Ossevoort MA; Ringers J; Kuhn EM; Boon L; Lorré K; van den Hout Y; Bruijn JA; de Boer M; Jonker M; de Waele P
    Transplantation; 1999 Oct; 68(7):1010-8. PubMed ID: 10532543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control.
    Contreras JL; Wang PX; Eckhoff DE; Lobashevsky AL; Asiedu C; Frenette L; Robbin ML; Hubbard WJ; Cartner S; Nadler S; Cook WJ; Sharff J; Shiloach J; Thomas FT; Neville DM; Thomas JM
    Transplantation; 1998 May; 65(9):1159-69. PubMed ID: 9603161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model.
    Kanmaz T; Fechner JJ; Torrealba J; Kim HT; Dong Y; Oberley TD; Schultz JM; Bloom DD; Katayama M; Dar W; Markovits J; Schuler W; Hu H; Hamawy MM; Knechtle SJ
    Transplantation; 2004 Mar; 77(6):914-20. PubMed ID: 15077037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic monitoring with Orthoclone OKT3 therapy.
    Schroeder TJ; First MR; Hurtubise PE; Marmer DJ; Martin DM; Mansour ME; Melvin DB
    J Heart Transplant; 1989; 8(5):371-80. PubMed ID: 2529358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic rejection of major histocompatibility complex class II-disparate skin grafts after anti-CD3 therapy: a model of antibody-independent transplant vasculopathy.
    Le Moine A; Flamand V; Noël JC; Fayt I; Goldman M; Abramowicz D
    Transplantation; 1998 Dec; 66(11):1537-44. PubMed ID: 9869097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of T lymphocytes for adhesion and cytokine expression by toxin-conjugated anti-CD3 monoclonal antibodies.
    Hamawy MM; Tsuchida M; Manthei ER; Dong Y; Fechner JE; Knechtle JS
    Transplantation; 1999 Sep; 68(5):693-8. PubMed ID: 10507490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.
    Elster EA; Xu H; Tadaki DK; Montgomery S; Burkly LC; Berning JD; Baumgartner RE; Cruzata F; Marx R; Harlan DM; Kirk AD
    Transplantation; 2001 Nov; 72(9):1473-8. PubMed ID: 11707732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients.
    Leone MR; Barry JM; Alexander SR; Melvin T; Striegel J; Reller K; Henell KR; Kimball J; Funnell MB; Goldstein G
    J Pediatr; 1990 May; 116(5):S86-91. PubMed ID: 2139465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in peripheral blood double-negative T-lymphocyte (CD3+ CD4- CD8-) populations associated with acute cellular rejection after liver transplantation.
    Crosbie OM; Costello PJ; O'Farrelly C; Hegarty JE
    Liver Transpl Surg; 1998 Mar; 4(2):141-5. PubMed ID: 9516566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates.
    Haanstra KG; Ringers J; Sick EA; Ramdien-Murli S; Kuhn EM; Boon L; Jonker M
    Transplantation; 2003 Mar; 75(5):637-43. PubMed ID: 12640302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful retreatment of allograft rejection with OKT3.
    First MR; Schroeder TJ; Hurtubise PE; Mansour ME; Penn I; Munda R; Balistreri WF; Alexander JW; Melvin DB; Fidler JP
    Transplantation; 1989 Jan; 47(1):88-91. PubMed ID: 2521410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection.
    Torrealba JR; Fernandez LA; Kanmaz T; Oberley TD; Schultz JM; Brunner KG; Peters D; Fechner JH; Dong Y; Hu H; Hamawy MM; Knechtle SJ
    Transplantation; 2003 Aug; 76(3):524-30. PubMed ID: 12923438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody.
    Meijer RT; Surachno S; Yong SL; Bemelman FJ; Florquin S; Ten Berge IJ; Schellekens PT
    Clin Exp Immunol; 2003 Sep; 133(3):485-92. PubMed ID: 12930378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.